Work

448P Real-world experience with CDK4/6 inhibitors for HR+/HER2-metastatic breast cancer (MBC)

Year: 2023

Type: article

Study design: Observational Study

Source: Annals of Oncology

DOI: 10.1016/j.annonc.2023.09.624

Authors: H.M.A. Abdallah, Y.I. Owoseni, A. Sultan, S. Ahmed, J. Wood, B. Varadhan, O. Ayodele

Institutions: Leicester Royal Infirmary, University Hospitals of Leicester NHS Trust

Language: English

Topic: Advanced Breast Cancer Therapies

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W4387825832

FWCI: 0.911

Cites:

Cited by: 7

Related to: 10